• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_SMART TOUCH BIDIRECTIONAL SF; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_SMART TOUCH BIDIRECTIONAL SF; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number UNK_SMART TOUCH BIDIRECTIONAL
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Paralysis (1997); Paresis (1998); Cardiac Tamponade (2226); Heart Failure/Congestive Heart Failure (4446); Pericarditis (4448)
Event Date 02/06/2023
Event Type  Injury  
Event Description
This complaint is from a literature source-the following literature cite has been reviewed- okamatsu h, okumura k, onishi f, yoshimura a, negishi k, tsurugi t, tanaka y, nakao k, sakamoto t, koyama j.Safety and efficacy of ablation index-guided atrial fibrillation ablation in octogenarians.Clin cardiol.2023 jul;46(7):794-800.Doi: 10.1002/clc.24031.Epub 2023 may 18.Pmid: 37199002; pmcid: pmc10352973.Objective/methods/study data:the study aimed to compare the efficacy and safety of ai-guided af ablation between af patients aged =80 years (group 1) and <80 (group 2).We aimed to compare the efficacy and safety of ai-guided af ablation between af patients aged =80 years (group 1) and <80 (group 2).: they retrospectively reviewed 2087 af patients undergoing their first ai- guided af ablation in our hospital.We compared the atrial tachyarrhythmia (at) recurrence and procedure-related complication rate between group 1 (n = 193) and group 2 (n = 1894).The mean age was 83.0 (interquartile range [iqr] 81.0, 84.0) years in group 1 and 67.0 (iqr 60.0, 72.0) in group 2.Af type was significantly different between the two groups: of group 1 patients, 120 (62.2%) had paroxysmal af, 61 (31.6%) persistent af, and 12 (6.2%) long-standing persistent af, while of group 2 patients, 1016 (53.6%) paroxysmal af, 582 (30.7%) persistent af, and 296 (15.6%) long- standing persistent af (p =.001).Unadjusted at recurrence-free survival curves showed similar at recurrence-free survival between the two groups (p =.67 by log- rank test).After the adjustment for af type, the survival curve was similar between them (hazard ratio, 1.24; 95% ci [0.92¿1.65]; p =.15, group 1 vs.Group 2).The rate of procedure-related complications was similar between the two groups (3.1% vs.3.0%, respectively, p =.83).Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: thermocool smarttouch surround flow; biosense webster).Other biosense webster devices that were also used in this study: 8fr soundstar ultrasound catheter (biosense webster), carto3 system, vizigo; johnson & johnson, guidee leftee; japan lifeline).Non-biosense webster devices that were also used in this study: 8.5 fr long sheaths (sl0; st jude medical) , 8.5 fr deflectable sheath (agilis; st jude medical), adverse event(s) and provided interventions qty 12 -cardiac tamponade ( 3 in group 1 and 9 in group 2).Qty 9 - phrenic nerve injury ( 1 in group 1 and 8 in group 2).Qty 9 - gastric hypomotility ( 1 in group 1 and 9 in group 2).Qty 2- stroke/thromboembolic events ( from group 2).Qty 9- heart failure ( from group 2).Qty 9 - pericarditis ( ( from group 2).Qty 4- nasal bleeding related to nasal airway device ( from group 2).
 
Manufacturer Narrative
This complaint is from a literature source-the following literature cite has been reviewed- okamatsu h, okumura k, onishi f, yoshimura a, negishi k, tsurugi t, tanaka y, nakao k, sakamoto t, koyama j.Safety and efficacy of ablation index-guided atrial fibrillation ablation in octogenarians.Clin cardiol.2023 jul;46(7):794-800.Doi: 10.1002/clc.24031.Epub 2023 may 18.Pmid: 37199002; pmcid: pmc10352973.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc, or its employees that the report constitutes an admission that the product, biosense webster inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer¿s reference number: (b)(4).
 
Manufacturer Narrative
On 1-sep-2023, the product investigation was completed as the complaint device was not returned.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturer record evaluation cannot be conducted because the no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_SMART TOUCH BIDIRECTIONAL SF
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key17665091
MDR Text Key322478090
Report Number2029046-2023-01964
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/31/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_SMART TOUCH BIDIRECTIONAL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/01/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
8.5 FR DEFLECTABLE SHEATH; 8.5 FR LONG SHEATHS (SL0, ST JUDE MEDICAL); 8FR SOUNDSTAR ULTRASOUND CATHETER; CARTO3 SYSTEM; GUIDEE LEFTEE; THERMOCOOL SMARTTOUCH SURROUND FLOW; VIZIGO
Patient Outcome(s) Life Threatening;
-
-